Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00002054
NCT00002054
View on ClinicalTrials.gov
A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients
NA
Completed
INTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
Pneumonia, Pneumocystis Carinii
HIV Infections
Interventions
DRUG
Pentamidine isethionate
Trial Locations (1)
14603
Fisons Corp, Rochester
All Listed Sponsors
lead
Fisons
INDUSTRY